Molecular Hybridization of Clinically Relevant P2X7 Antagonists
ChemMedChem · 14.07.2026 · 21 (13)
DOI: 10.1002/cmdc.70371 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 08.07.2026. Verfasst von Nicholas B Lynch und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry, Faculty of Science, The University of Sydney, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Receptors, Purinergic P2X7, Purinergic P2X Receptor Antagonists. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Government Research Training Program..
Abstract (Originalsprache)
The P2X7 receptor plays a pivotal role in the development of neurodegenerative disease states, yet no therapies targeting this receptor have reached the market to date. This work utilized a hybridization approach to combine clinically relevant antagonists AZD‐9056 and JNJ‐54175446 to discover new P2X7 antagonists. Here, we report the synthesis and in vitro and in silico evaluation of a library of 22 compounds to explore new chemical space around these clinically validated molecules. This study emphasizes the value of molecular hybridization in drug discovery and provides the basis for future P2X7 receptor antagonist development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry, Faculty of Science, The University of Sydney, Sydney, New South Wales, Australia.
- Central Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
ORCID-Profile: Eryn Werry, Michael Kassiou
Förderung
- Australian Government Research Training Program.
Zitieren
APA
Lynch, N. B., Agius, C. T. A., McKenzie, A. D. J., O'Driscoll, J., Tolmie, A., Garrett, T. R., Werry, E., & Kassiou, M. (2026). Molecular Hybridization of Clinically Relevant P2X7 Antagonists. ChemMedChem, 21(13). https://doi.org/10.1002/cmdc.70371
Vancouver
Lynch NB, Agius CTA, McKenzie ADJ, O'Driscoll J, Tolmie A, Garrett TR, et al. Molecular Hybridization of Clinically Relevant P2X7 Antagonists. ChemMedChem. 2026;21(13). doi:10.1002/cmdc.70371
BibTeX
@article{Lynch2026,
author = {Lynch, Nicholas B and Agius, Charleigh T A and McKenzie, André D J and O'Driscoll, Jessica and Tolmie, Angus and Garrett, Taylor R and Werry, Eryn and Kassiou, Michael},
title = {Molecular Hybridization of Clinically Relevant P2X7 Antagonists},
journal = {ChemMedChem},
year = {2026},
volume = {21},
number = {13},
doi = {10.1002/cmdc.70371}
}
EUVIMED